Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

                    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose                           ( print page 514)                        confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.                

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  Therapeutic Agents that Target Cancer Stem Cells.                    

*Date:*                         March 10-11, 2015.                    

*Time:*                         11:00 a.m. to 7:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 4W032, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Kenneth L. Bielat, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W244, Bethesda, MD 20892-9750, 240-276-6373,                         *bielatk@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Innovative Research in Cancer Nanotechnology (IRCN).                    

*Date:*                         March 19-20, 2015.                    

*Time:*                         8:00 a.m. to 7:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel and Conference Center 5701 Marinelli Road Bethesda, MD 20852.                    

*Contact Person:*                         Kenneth L. Bielat, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W244, Bethesda, MD 20892-9750, 240-276-6373,                         *bielatk@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Advance Culture Systems for Expansion of Cancer Stem Cells.                    

*Date:*                         March 25-26, 2015.                    

*Time:*                         11:00 a.m. to 7:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 2E032, Rockville, MD 20850, (Telephone Conference Call).                    

*Contact Person:*                         Kenneth L. Bielat, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W244, Bethesda, MD 20892-9750, 240-276-6373,                         *bielatk@mail.nih.gov*.                    

                        Information is also available on the Institute's/Center's home page:                         *http://deainfo.nci.nih.gov/​advisory/​sep/​sep.htm,*                         where an agenda and any additional information for the meeting will be posted when available.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: December 30, 2014.

David Clary, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2014-30879 Filed 1-5-15; 8:45 am]

BILLING CODE 4140-01-P